Tectonic Therapeutic (TECX) Profit After Tax (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Profit After Tax came in at -$25.2 million in Q1 2026, down 58.69% year-on-year from -$61.1 million in Q1 2025, and down 30.95% on a QoQ basis from -$19.3 million in Q4 2025.
Tectonic Therapeutic (TECX) Profit After Tax (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Profit After Tax data on file, last reported at -$25.2 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 58.69% year-over-year to -$25.2 million in Q1 2026; TTM through Mar 2026 was -$83.5 million, a 42.34% decrease from a year earlier, with the FY2025 full-year figure at -$74.2 million, down 27.93% from the prior year.
- Profit After Tax for Q1 2026 stood at -$25.2 million, down from -$19.3 million in the prior quarter.
- Over the last five years, Profit After Tax for TECX reached as high as -$7.8 million in Q4 2023 and fell as low as -$29.8 million in Q1 2022.
- Historically, Profit After Tax has averaged -$18.0 million across 5 years, with a median of -$17.7 million in 2024.
- Across the five-year window, Profit After Tax soared 68.66% in 2023 and slumped 76.22% in 2024, its largest moves.
- Year by year, Profit After Tax stood at -$25.0 million in 2022, then surged by 68.66% to -$7.8 million in 2023, then plunged by 57.93% to -$12.4 million in 2024, then slumped by 55.56% to -$19.3 million in 2025, then tumbled by 30.95% to -$25.2 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$25.2 million in Q1 2026, -$19.3 million in Q4 2025, and -$19.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | -25.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.24 Mn |
| Dec 31, 2025 | -19.28 Mn |
| Sep 30, 2025 | -19.04 Mn |
| Jun 30, 2025 | -19.98 Mn |
| Mar 31, 2025 | -15.91 Mn |
| Dec 31, 2024 | -12.39 Mn |
| Sep 30, 2024 | -17.72 Mn |
| Jun 30, 2024 | -12.67 Mn |
| Mar 31, 2024 | -15.22 Mn |
| Dec 31, 2023 | -7.85 Mn |
| Sep 30, 2023 | -10.05 Mn |
| Jun 30, 2023 | -10.46 Mn |
| Mar 31, 2023 | -14.45 Mn |
| Dec 31, 2022 | -25.03 Mn |
| Sep 30, 2022 | -22.97 Mn |
| Jun 30, 2022 | -28.05 Mn |
| Mar 31, 2022 | -29.83 Mn |
| Dec 31, 2021 | -28.23 Mn |
| Sep 30, 2021 | -32.61 Mn |
| Jun 30, 2021 | -31.39 Mn |